Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Cancer · Metastatic Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Study coordinator · ahumbert@wakehealth.edu · 3367136912
Contact: Principal Investigator (Ravi K Paluri, MD)

Study leads

Ravi Paluri, MD
Principal Investigator
Wake Forest Baptist Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

Solid Tumor, Adult · Pancreatic Cancer · Virus-associated Tumors

Abroad (travel likely)RecruitingPHASE2

Bordeaux, France · Brest, France

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Localized Pancreatic Adenocarcinoma · Resectable Pancreatic Ductal Adenocarcinoma · Stage 0 Pancreatic Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Rochester, United States

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Solid Tumors · Advanced Cancer · Renal Cancer

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Tampa, United States

Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

Advanced Pancreatic Cancer (Part 1)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China · Beijing, China